IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.151
AS - Asia 19.417
NA - Nord America 14.126
SA - Sud America 4.321
AF - Africa 385
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 12
Totale 58.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.394
RU - Federazione Russa 11.733
SG - Singapore 7.165
CN - Cina 5.829
BR - Brasile 3.537
HK - Hong Kong 2.480
IT - Italia 2.387
SE - Svezia 1.884
VN - Vietnam 1.674
FR - Francia 924
DE - Germania 838
BD - Bangladesh 689
GB - Regno Unito 540
IN - India 443
FI - Finlandia 378
CA - Canada 335
AR - Argentina 288
RO - Romania 288
MX - Messico 235
AT - Austria 190
NL - Olanda 189
IE - Irlanda 184
PL - Polonia 166
JP - Giappone 151
ZA - Sudafrica 149
ES - Italia 142
ID - Indonesia 141
TR - Turchia 132
EC - Ecuador 131
IQ - Iraq 130
CO - Colombia 104
UA - Ucraina 76
PK - Pakistan 70
VE - Venezuela 57
PY - Paraguay 56
NP - Nepal 52
MA - Marocco 50
SA - Arabia Saudita 50
CL - Cile 49
LT - Lituania 49
UZ - Uzbekistan 48
PH - Filippine 45
MY - Malesia 44
PE - Perù 43
TN - Tunisia 42
UY - Uruguay 36
EG - Egitto 35
MD - Moldavia 34
JM - Giamaica 33
KE - Kenya 33
AE - Emirati Arabi Uniti 31
CR - Costa Rica 26
IR - Iran 26
IL - Israele 25
BE - Belgio 24
DZ - Algeria 24
AU - Australia 21
CH - Svizzera 20
PT - Portogallo 20
JO - Giordania 19
TW - Taiwan 18
BH - Bahrain 16
HN - Honduras 16
DO - Repubblica Dominicana 14
KZ - Kazakistan 14
LB - Libano 14
BO - Bolivia 13
GT - Guatemala 13
OM - Oman 13
AZ - Azerbaigian 12
NI - Nicaragua 12
KR - Corea 11
RS - Serbia 11
GR - Grecia 10
AL - Albania 9
PA - Panama 9
PS - Palestinian Territory 9
TH - Thailandia 9
BG - Bulgaria 8
CY - Cipro 8
PR - Porto Rico 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
CZ - Repubblica Ceca 7
GE - Georgia 7
HU - Ungheria 7
SN - Senegal 7
AO - Angola 6
BB - Barbados 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
EU - Europa 6
GY - Guiana 6
KG - Kirghizistan 6
KH - Cambogia 6
KW - Kuwait 6
QA - Qatar 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
NZ - Nuova Zelanda 5
Totale 58.355
Salva come PNG Salva come JPEG
Città #
Singapore 3.239
Moscow 2.463
Hong Kong 2.444
Dallas 2.257
Ashburn 2.103
San Jose 1.953
Shanghai 1.004
Hefei 881
Lauterbourg 730
Beijing 676
New York 663
Lawrence 593
Princeton 584
Milan 581
Ho Chi Minh City 578
Los Angeles 416
Hanoi 368
São Paulo 347
Santa Clara 253
Nuremberg 222
Boardman 204
Rome 201
Munich 198
Helsinki 191
Dublin 183
Orem 182
London 170
Warsaw 134
Rio de Janeiro 128
Tokyo 118
Chennai 116
Montreal 113
Washington 103
Brooklyn 102
Denver 102
Council Bluffs 100
Chicago 98
Turku 96
The Dalles 95
Frankfurt am Main 93
Poplar 91
Pune 91
Atlanta 87
Lappeenranta 87
Johannesburg 85
Vienna 85
Stockholm 83
Guangzhou 82
Mexico City 81
Phoenix 81
Belo Horizonte 79
Da Nang 74
Seattle 70
Columbus 67
Buffalo 66
Houston 65
Manchester 65
Haiphong 62
Brasília 61
Toronto 61
Naples 60
Cesano Boscone 58
San Francisco 56
Baghdad 55
Ankara 53
Boston 53
Shenzhen 52
Amsterdam 51
Tianjin 49
Mumbai 45
Biên Hòa 44
Curitiba 44
Campinas 43
Dhaka 43
Quito 43
Hangzhou 42
Bologna 41
Porto Alegre 41
Tashkent 41
Turin 41
Guayaquil 38
Guarulhos 37
Florence 35
Salvador 35
Thái Bình 34
St Petersburg 33
Hải Dương 32
Landshut 32
New Delhi 32
Santo André 32
Changsha 31
Ribeirão Preto 31
Las Vegas 30
Brescia 29
Cape Town 29
Nairobi 28
Charlotte 27
Jakarta 27
Kingston 27
Paris 27
Totale 28.186
Salva come PNG Salva come JPEG
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 357
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes 306
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis 210
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 193
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 192
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 183
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 179
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 176
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 176
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 174
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3 172
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 169
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 167
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 167
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 160
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 160
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 158
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 155
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 154
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 153
Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol 151
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 149
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 144
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 144
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma 143
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 142
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 142
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 142
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 142
A delphic consensus assessment: Imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management 142
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 139
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 137
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 137
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 136
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 135
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 134
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 134
A multimodality test to guide the management of patients with a pancreatic cyst 133
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 132
A preoperative score to predict early death after pancreatic cancer resection 130
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 129
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 129
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 129
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 128
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 128
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 127
European evidence-based guidelines on pancreatic cystic neoplasms 126
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 125
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 125
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery 124
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 124
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 124
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 123
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 123
The impact of preoperative anemia on pancreatic resection outcomes 122
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 121
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 120
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 119
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 119
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 118
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 118
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 118
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 116
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 116
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 116
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 115
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 115
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 114
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 114
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 114
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 114
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. 113
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 113
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 113
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 113
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 112
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 112
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 112
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 111
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 111
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 110
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 110
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 110
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 109
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 109
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 109
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer 108
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 108
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 108
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 108
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 107
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 107
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 107
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 107
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 106
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 106
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 106
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 106
Totale 13.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 354.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 354.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022307 0 2 21 123 31 15 16 9 21 17 9 43
2022/20233.706 1.329 743 218 48 39 397 325 325 167 32 34 49
2023/20242.648 70 132 296 250 249 555 74 268 43 105 189 417
2024/202512.216 1.365 326 326 364 425 1.064 1.795 1.006 2.053 1.594 893 1.005
2025/202640.335 2.730 3.035 2.755 5.243 2.859 1.233 3.613 2.892 10.725 2.366 1.566 1.318
Totale 59.426